<SEC-DOCUMENT>0001213900-18-006125-index.html : 20180514
<SEC-HEADER>0001213900-18-006125.hdr.sgml : 20180514
<ACCEPTANCE-DATETIME>20180514164656
ACCESSION NUMBER:		0001213900-18-006125
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20180514
DATE AS OF CHANGE:		20180514
EFFECTIVENESS DATE:		20180514

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RELMADA THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001553643
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				455401931
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-224920
		FILM NUMBER:		18831408

	BUSINESS ADDRESS:	
		STREET 1:		750 THIRD AVENUE, 9TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		646-677-3853

	MAIL ADDRESS:	
		STREET 1:		750 THIRD AVENUE, 9TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CAMP NINE, INC.
		DATE OF NAME CHANGE:	20120706
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>fs82018_relmadatherap.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
Document 1 - file: fs82018_relmadatherap.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>fs82018ex5-1_relmada.htm
<DESCRIPTION>OPINION OF FENNEMORE CRAIG, P.C
<TEXT>
Document 2 - file: fs82018ex5-1_relmada.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>fs82018ex23-1_relmada.htm
<DESCRIPTION>CONSENT OF GBH CPAS, PC
<TEXT>
Document 3 - file: fs82018ex23-1_relmada.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: ex5-1_001.jpg

</DOCUMENT>
</SEC-DOCUMENT>